Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

October’s top stories: GSK shingles vaccine, Pfizer’s Inflectra injection in US

GSK submitted a biologics licence application to the FDA for its candidate shingles vaccine Shingrix, Pfizer announced its introduction of Inflectra (infliximab-dyyb) for injection in the US and Teva agreed to sell Actavis Generics assets and operations in the UK and Ireland for £603m. Pharmaceutical Technology wraps up the key headlines from October.

Go Top